---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-003414"
form_type: "8-K"
ticker: "HSDT"
cik: "0001610853"
company_name: "Solana Co"
filed_at: "2024-03-15T23:59:59+00:00"
generated_at: "2026-06-04T17:18:10.954078+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Helius Medical amends bylaws: quorum cut to one-third, universal proxy rules adopted

## Summary
- Quorum requirement reduced from majority to one-third of voting power for stockholder meetings.
- Universal proxy rules adopted per SEC Rule 14a-19; only Board nominees allowed unless complying.
- Enhanced disclosure for stockholder director nominations and proposals; board may request additional info.
- Special meeting nomination requires 10% voting power; stockholder status at notice and record date.
- Technical and clarifying changes to reflect updates in Delaware General Corporation Law.

## SEC filing metadata
- accession: 0001558370-24-003414
- form_type: 8-K
- ticker: HSDT
- cik: 0001610853
- company_name: Solana Co
- filed_at: 2024-03-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610853/000155837024003414/0001558370-24-003414-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610853/000155837024003414/hsdt-20240312x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-003414
- JSON: https://secwatch.observer/filing/0001558370-24-003414.json
- Plain text: https://secwatch.observer/filing/0001558370-24-003414.txt

## Key facts
- Governance Changes
  Solana Co: Amended and restated bylaws to reduce stockholder meeting quorum, address universal proxy rules, update disclosure requirements, impose new special meeting nomination conditions, and clarify personal jurisdiction (effective 2024-03-12).
  - Change: bylaw amendment
  - Effective: 2024-03-12
  source text: On March 12, 2024, the Board of Directors (the “ Board ”) of Helius Medical Technologies, Inc., a Delaware corporation (the “ Company ”) approved and adopted the Company’s Second Amended and Restated Bylaws (the “ Second Amended and Restated Bylaws ”), which became effective the same day.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1610853/000155837024003414/0001558370-24-003414-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.